The Healthtech Podcast

← The Healthtech Podcast28 okt · 1 u 15 min

#469 What the evidence says about longevity and NAD supplements

#469 What the evidence says about longevity and NAD supplements28 okt1 u 15 min

<p>A lot of the longevity industry is selling certainty it does not have. Dr Prarthana Venkatesh, founder and CEO of Longevita and a London-trained surgeon who went from core surgical training to McKinsey before starting the company, joins James to separate what the evidence actually supports from what is just demand.</p><p>They work through the peptide market, where consumer appetite has run ahead of human trial data entirely, and the drip clinics and full body scans now being sold to people with no way of judging them. Prarthana explains why she spent two years bringing every dose in her 12-ingredient formulation down rather than up, and why overdoing the NAD precursors sold as NAD supplements is the quiet problem nobody in the category wants to discuss. There is a candid stretch on price: she puts the cost of making most supplements below GBP 20 a box, and asks why a blood test that costs GBP 20 to run reaches consumers at hundreds.</p><p>James makes the case for looking at supplementation from first principles, once you strip away the word supplement. Prarthana talks about growing up in Myanmar, setting up rural health camps at 17, and what she saw at Chelsea and Westminster during COVID that pushed her out of surgery and into prevention.</p><p>This is a conversation between two doctors and is not medical advice.</p><p>Prarthana on LinkedIn: https://uk.linkedin.com/in/dr-prarthana-v</p><p>Longevita: https://www.longevita-uk.com</p><p><br /></p>